Chronic kidney disease (CKD) affects an estimated 37 million Americans or more than 1 in 7 U.S. adults. Nearly 808,000 people in the United States are living with end-stage renal disease (ESKD) that requires dialysis or kidney transplant.
![Kidney](/sites/default/files/styles/az_natural/public/2023-09/AdobeStock_475897698.jpeg?itok=9bs769ut)
The Program for Kidney Health and Disease includes investigators in the Department of Physiology and from across the University of Arizona who are actively engaged in the study of kidney health and disease. Current areas of focus include genetics, epigenetics, and multi-omics of human kidney function and disease, polycystic kidney disease, neuromodulation of kidney function, kidney organoids, acute kidney injury, and kidney metabolism.
Medicare spending for beneficiaries with CKD (not including ESKD) ages 66 or older exceeded $75 billion in 2020, representing 25.2% of Medicare spending in this age group. Medicare-related spending for beneficiaries with ESKD totaled $50.8 billion in 2020.
Other kidney problems include acute kidney injury, kidney tumors, kidney cysts, kidney stones, and kidney infections.